Jefferies Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-33,400
Closed -$3.07M 1926
2021
Q4
$3.07M Buy
33,400
+9,400
+39% +$1.12M 0.02% 633
2021
Q3
$3.04M Buy
+24,000
New +$3.49M 0.02% 598
2020
Q1
Sell
-45,200
Closed -$3.78M 2653
2019
Q4
$3.78M Buy
45,200
+10,100
+29% +$769K 0.03% 662
2019
Q3
$2.38M Buy
+35,100
New +$2.31M 0.02% 968

Other funds holding TDOC

Jefferies Group's TDOC Position: Q3 2022 in Review

Jefferies Group sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 8,000 shares — an estimated $266K sold.

Jefferies Group first reported a position in TDOC in Q3 2016 and held it in 19 quarters. The position peaked at $22.5M in Q4 2019. 482 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Jefferies Group reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • Jefferies Group sold 8,000 Teladoc Health shares in Q3 2022, an estimated $266K.
  • Jefferies Group first reported a position in Teladoc Health in Q3 2016 and held it in 19 quarters.
  • Jefferies Group's Teladoc Health position peaked at $22.5M in Q4 2019.
  • 482 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.